EGFR and neoplasm: Arong, Gaowa et al. synthesized an EGFR-lytic peptide for PDAC treatment based on the chemical coupling of lysing peptides and peptides targeting epidermal growth factor receptors (EGFRs) overexpressed on the surface of tumor cells.